Caveolin-1 ameliorates acetaminophen-aggravated inflammatory damage and lipid deposition in non-alcoholic fatty liver disease via the ROS/TXNIP/NLRP3 pathway
Authors:
- 20 December 2022
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 114, 109558
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81970516)
This publication has 53 references indexed in Scilit:
- Acetaminophen‐induced liver injury in obesity and nonalcoholic fatty liver diseaseLiver International, 2014
- The thioredoxin antioxidant systemFree Radical Biology and Medicine, 2014
- NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in miceHepatology, 2013
- IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in miceJournal of Clinical Investigation, 2012
- CAVEOLIN-1: Role in Cell Signaling2012
- Elevated Inflammatory Response in Caveolin-1-deficient Mice with Pseudomonas aeruginosa Infection Is Mediated by STAT3 Protein and Nuclear Factor κB (NF-κB)Journal of Biological Chemistry, 2011
- Role of caspase-1 and interleukin-1β in acetaminophen-induced hepatic inflammation and liver injuryToxicology and Applied Pharmacology, 2010
- Potential role of caveolin-1 in acetaminophen-induced hepatotoxicityToxicology and Applied Pharmacology, 2010
- Caveolin-1 and Lipid Rafts in Confluent BeWo Trophoblasts: Evidence for Rock-1 Association with Caveolin-1Placenta, 2007
- Caveolin, cholesterol, and lipid bodiesSeminars in Cell & Developmental Biology, 2005